• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antimicrobial resistance of in Korea for two decades.韩国二十年来的抗菌药物耐药性。 (你提供的原文似乎不完整,“Antimicrobial resistance of in Korea”这里“of”后面缺少内容)
Investig Clin Urol. 2025 Sep;66(5):455-461. doi: 10.4111/icu.20250106.
2
Molecular mechanisms of macrolide and fluoroquinolone resistance among Korean isolates of over a period of five years 2014-2019.2014-2019 年韩国分离株中大环内酯类和氟喹诺酮类耐药的分子机制研究。
J Med Microbiol. 2021 Nov;70(11). doi: 10.1099/jmm.0.001460.
3
Prevalence and epidemiology of and the absence of macrolide resistance in among pregnant women attending antenatal care in Zambia.赞比亚接受产前护理的孕妇中[具体内容缺失,无法准确翻译]的患病率、流行病学情况及大环内酯类耐药性的缺失情况。
Front Public Health. 2025 May 9;13:1576376. doi: 10.3389/fpubh.2025.1576376. eCollection 2025.
4
Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis.生殖支原体对大环内酯类和氟喹诺酮类药物耐药性的演变模式:一项更新的系统评价和荟萃分析。
Lancet Microbe. 2025 Mar 24:101047. doi: 10.1016/j.lanmic.2024.101047.
5
Symptomatic Mycoplasma genitalium infections in men who have sex with men and trans women: Should we skip macrolides?
Int J Med Microbiol. 2025 Sep;320:151667. doi: 10.1016/j.ijmm.2025.151667. Epub 2025 Jul 25.
6
A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro.体外诱导产生的生殖支原体中一种新的阿奇霉素耐药突变。
J Antimicrob Chemother. 2025 Jul 1;80(7):2044-2050. doi: 10.1093/jac/dkaf174.
7
Automated molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations.自动化分子大环内酯类耐药性检测及核酸靶点半定量分析:患者人口统计学因素考量
Microbiol Spectr. 2025 Jul;13(7):e0073825. doi: 10.1128/spectrum.00738-25. Epub 2025 May 22.
8
Performance of the first commercial dual resistance assay, AmpliSens -ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of resistance mutations in St. Petersburg, Russia.俄罗斯圣彼得堡地区首个商业化的双重耐药检测试剂盒(AmpliSens-ML/FQ-Resist-FL)的性能评估,用于检测潜在的大环内酯类和氟喹诺酮类耐药相关突变以及耐药突变的流行率。
Sex Transm Infect. 2023 May;99(3):191-194. doi: 10.1136/sextrans-2021-055249. Epub 2022 Jun 16.
9
Effectiveness of intramuscular spectinomycin in difficult-to-treat Mycoplasma genitalium urethritis in four cases.肌肉注射壮观霉素治疗4例难治性生殖支原体尿道炎的疗效
J Infect Chemother. 2025 Sep;31(9):102775. doi: 10.1016/j.jiac.2025.102775. Epub 2025 Jul 24.
10
Factors that contribute to the success of primary isolation of from clinical samples.有助于从临床样本中成功进行初次分离的因素。 (注:原文中“from clinical samples”前似乎少了个具体的东西,比如某种病原体等,这里按字面翻译)
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002040.

本文引用的文献

1
Physicians', pharmacists', and nurses' education of patients about antibiotic use and antimicrobial resistance in primary care settings: a qualitative systematic literature review.初级保健机构中医生、药剂师和护士对患者进行抗生素使用及抗菌药物耐药性教育的质性系统文献综述
Front Antibiot. 2025 Jan 9;3:1507868. doi: 10.3389/frabi.2024.1507868. eCollection 2024.
2
2023 Korean sexually transmitted infections treatment guidelines for by KAUTII.2023 年韩国性传播感染治疗指南(KAUTII)
Investig Clin Urol. 2024 Jan;65(1):16-22. doi: 10.4111/icu.20230314.
3
Prevalence of infection with antimicrobial resistance mutations among gay sex workers in China.中国男同性恋性工作者中具有抗菌药物耐药突变感染的流行率。
Int J STD AIDS. 2023 Jul;34(8):518-524. doi: 10.1177/09564624231160676. Epub 2023 Mar 17.
4
Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure.生殖道支原体变异体:时间趋势及与莫西沙星耐药的相关性。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0027822. doi: 10.1128/aac.00278-22. Epub 2022 Apr 27.
5
Molecular mechanisms of macrolide and fluoroquinolone resistance among Korean isolates of over a period of five years 2014-2019.2014-2019 年韩国分离株中大环内酯类和氟喹诺酮类耐药的分子机制研究。
J Med Microbiol. 2021 Nov;70(11). doi: 10.1099/jmm.0.001460.
6
Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.大环内酯类和氟喹诺酮类相关突变在 2016-2018 年中国广州性传播感染诊所就诊的男性和女性患者的生殖支原体中的回顾性研究。
BMC Infect Dis. 2020 Dec 11;20(1):950. doi: 10.1186/s12879-020-05659-3.
7
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.喹诺酮类药物:作用机制、致死性及其对抗生素耐药性的贡献。
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
8
An overview of the antimicrobial resistance mechanisms of bacteria.细菌抗菌耐药机制概述。
AIMS Microbiol. 2018 Jun 26;4(3):482-501. doi: 10.3934/microbiol.2018.3.482. eCollection 2018.
9
Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.日本生殖支原体中与大环内酯类和/或氟喹诺酮类耐药相关突变的流行情况监测。
J Infect Chemother. 2018 Nov;24(11):861-867. doi: 10.1016/j.jiac.2018.08.009. Epub 2018 Sep 3.
10
Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure.生殖支原体:全基因组序列分析、重组和种群结构。
BMC Genomics. 2017 Dec 28;18(1):993. doi: 10.1186/s12864-017-4399-6.

韩国二十年来的抗菌药物耐药性。 (你提供的原文似乎不完整,“Antimicrobial resistance of in Korea”这里“of”后面缺少内容)

Antimicrobial resistance of in Korea for two decades.

作者信息

Lee Gilho, Park Heeyoon, Seo Yumi, Lee Seung-Ju

机构信息

Department of Urology, Dankook University College of Medicine, Cheonan, Korea.

Department of Urology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Investig Clin Urol. 2025 Sep;66(5):455-461. doi: 10.4111/icu.20250106.

DOI:10.4111/icu.20250106
PMID:40897664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12437570/
Abstract

PURPOSE

Antimicrobial-resistant (AMR) has become a global concern. To assess AMR patterns in Korea, we analyzed the genetic diversity of the AMR-determining sites (ARDS) in across in 285 samples collected over two decades.

MATERIALS AND METHODS

-positive samples were collected from various groups: males at one referral center (ORC) from 2014 to 2019 (G1; 43) and from 2020 to 2023 (G2; 54), males at primary care clinics (PCCs) in 2018-2019 (G3; 84), female sex workers at a regional healthcare center in 2004 (G4; 51), and females at PCCs in 2018-2019 (G5; 53). Sanger sequencing was performed at positions 2058/2059 in the 23S rRNA gene and positions GyrA95, GyrA99, ParC83, and ParC87 of topoisomerase IV genes in .

RESULTS

In 2004, mutations were rare with S83I (0.0%), M95I (3.4%), and A2059G (10.5%). By 2020-2023, ARDS mutations had become common, peaking at S83I (83.3%) and A2059G (70.4%). No sex differences were observed in ARDS mutations between G3 and G5. A comparison of mutations in males at the ORC showed significant differences in A2059G and S83I between pre-2020 (G1) and post-2020 (G2). Males at the ORC (G1) had higher mutation rates in A2059G, GyrA95, and GyrA99 compared to males at PCCs (G3).

CONCLUSIONS

Currently, referred males exhibit a rapid increase in AMR, and the synergy between A2059G and S83I/R/N mutations raises concerns regarding the emergence of pan-drug-resistant , potentially leading to an irreversible crisis in treatment options in Korea.

摘要

目的

抗菌药物耐药性(AMR)已成为全球关注的问题。为评估韩国的AMR模式,我们分析了二十多年来收集的285份样本中AMR决定位点(ARDS)的遗传多样性。

材料与方法

从不同组收集阳性样本:2014年至2019年在一个转诊中心(ORC)的男性(G1组;43例)和2020年至2023年的男性(G2组;54例),2018 - 2019年基层医疗诊所(PCCs)的男性(G3组;84例),2004年在一个地区医疗中心的女性性工作者(G4组;51例),以及2018 - 2019年PCCs的女性(G5组;53例)。对23S rRNA基因的2058/2059位点以及拓扑异构酶IV基因的GyrA95、GyrA99、ParC83和ParC87位点进行桑格测序。

结果

2004年,S83I(0.0%)、M95I(3.4%)和A2059G(10.5%)的突变很少见。到2020 - 2023年,ARDS突变变得普遍,S83I(83.3%)和A2059G(70.4%)达到峰值。G3组和G5组在ARDS突变方面未观察到性别差异。对ORC男性的突变比较显示,2020年前(G1组)和2020年后(G2组)在A2059G和S83I方面存在显著差异。与PCCs的男性(G3组)相比,ORC的男性(G1组)在A2059G、GyrA95和GyrA99方面的突变率更高。

结论

目前,转诊的男性中AMR迅速增加,A2059G与S83I/R/N突变之间的协同作用引发了对泛耐药菌出现的担忧,这可能导致韩国治疗选择出现不可逆转的危机。